Clinical Trial Update: A Study of the Efficacy of Intravenous Esketamine in Adult Patients With Treatment-Resistant Depression [Phase 2]

View source ↗

Summary

This Phase 2 trial update reports on the efficacy of intravenous esketamine in adults with treatment-resistant major depressive disorder. The study has complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Esketamine (intravenous) (esketamine)

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: Major Depressive Disorder | Phase 2 | Status: COMPLETED